Search Results for keywords:"National Institutes of Health"

The National Institutes of Health announced a closed meeting for the National Center for Advancing Translational Sciences Special Emphasis Panel. This meeting, scheduled for March 6, 2025, is focused on reviewing and evaluating grant applications related to clinical trial readiness for rare diseases. It will occur via video-assisted methods in Rockville, MD. The closed nature of the meeting is to protect confidential and personal information linked to the grant discussions.

The National Institute of Allergy and Infectious Diseases is holding a closed meeting on February 5, 2021, to review and evaluate contract proposals. This meeting will follow the guidelines of the Federal Advisory Committee Act and will not be open to the public to protect confidential trade secrets and personal information. The meeting will be conducted virtually at the National Institutes of Health in Rockville, MD. Interested parties can contact Kristina Wickham for more information.

The National Institute on Drug Abuse is holding several closed meetings in March 2021 to review and evaluate grant applications. These meetings are closed to the public to protect sensitive information, including trade secrets and personal privacy. They will be conducted virtually at the National Institutes of Health in Bethesda, MD. The meetings will cover various topics, including career development, using human cell animal chimera brains to study HIV, and studies on substance use prevention and treatment services.

The National Institute of Nursing Research is holding a closed virtual meeting to review and evaluate small business grant applications. This meeting, set for April 17, 2025, will take place from 1:00 p.m. to 2:00 p.m. and will not be open to the public due to privacy concerns related to confidential information about grant applications. Joshua R. Wolff, Ph.D., is the contact person for the meeting, which falls under the Health and Human Services Department and the National Institutes of Health.

The National Institute of Nursing Research has announced a change to the timing of their Special Emphasis Panel meeting. Originally scheduled from 10:00 a.m. to 2:00 p.m. on February 19, 2021, the meeting will now be held from 2:00 p.m. to 4:00 p.m. The meeting is not open to the public and will take place at Democracy One in Bethesda, Maryland.

The National Human Genome Research Institute is holding a closed meeting to review grant applications related to genetic counseling processes and practices. The meeting is scheduled for February 8, 2021, from 9:00 a.m. to 5:30 p.m. It will take place virtually at the National Institutes of Health in Bethesda, MD. The meeting is closed to the public to protect confidential information and the privacy of individuals involved with the grant applications.

The Eunice Kennedy Shriver National Institute of Child Health and Human Development has announced a closed meeting scheduled for May 6, 2025. The meeting will focus on reviewing and evaluating grant applications related to small businesses in rehabilitation and bioengineering. It will be conducted virtually to protect confidential information and personal privacy. Interested parties can contact Magnus A. Azuine, Ph.D., for more details.

The National Cancer Institute announced several upcoming closed meetings to review grant applications and contract proposals. These meetings will not be open to the public to protect confidential information and personal privacy. Each meeting is led by a Scientific Review Officer, and the topics include reviews for SBIR contracts, clinical and translational research, and various other cancer research initiatives. The meetings will take place via telephone conference calls from late February through early April 2021.

The National Institutes of Health (NIH) is announcing a closed meeting of the Heart, Lung, and Blood Initial Review Group, specifically for the Single-Site and Pilot Clinical Trials Review Committee. The meeting is scheduled for February 24-25, 2021, from 9:00 a.m. to 3:00 p.m. and will take place virtually. This meeting will be closed to the public to protect confidential information, such as trade secrets and personal data associated with the grant applications being reviewed.

The National Institutes of Health (NIH) is seeking approval from the Office of Management and Budget (OMB) for information collection related to the Cancer Therapy Evaluation Program (CTEP) and the Division of Cancer Prevention (DCP) under the National Cancer Institute (NCI). This information is crucial for managing clinical trials in cancer research, ensuring compliance with federal regulations, and improving processes. The request is part of the requirements of the Paperwork Reduction Act of 1995, and public comments are invited within 30 days of publication. There are no costs to respondents apart from their time, and the estimated annual burden is 151,792 hours.